Inventor · disambiguated record
Shomir Ghosh
Also filed as: GHOSH SHOMIR
72 granted patents·43 pending applications·357 citations·filing 2002–2024
99Inventor score
Files withNOVARTIS AG20MILLENNIUM PHARM INC16INNATE TUMOR IMMUNITY INC14CELGENE AVILOMICS RES INC11GILEAD APOLLO LLC10
Top patents by PatentIndex Score
115 records- 0194US7989465B24,6-disubstituted pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2009·Granted Aug 2, 2011·26 cites·4 claims
- 0293US10604542B2Cyclic dinucleotides for treating conditions associated with sting activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 0393US10556903B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Feb 11, 2020·12 cites·5 claims
- 0493US8309685B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2009·Granted Nov 13, 2012·20 cites·36 claims
- 0592US10533005B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted Jan 14, 2020·9 cites·41 claims
- 0691US8513242B2Pyrimidine compounds and methods of making and using sameCHIANG PHOEBE·Filed 2009·Granted Aug 20, 2013·30 cites·13 claims
- 0790US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0890US10800791B2Triazole ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2019·Granted Oct 13, 2020·3 cites·3 claims
- 0990US8329901B24,6-disubstitued pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted Dec 11, 2012·11 cites·5 claims
- 1090US7982036B24,6-disubstitued pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·13 cites·12 claims
- 1190US7504508B2PGD2 receptor antagonists for the treatment of inflammatory diseasesMILLENNIUM PHARM INC·Filed 2005·Granted Mar 17, 2009·14 cites·2 claims
- 1289US10961270B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Mar 30, 2021·2 cites·7 claims
- 1389US8981084B2Oxadiazole HDAC inhibitorsBALOGLU ERKAN·Filed 2011·Granted Mar 17, 2015·19 cites·7 claims
- 1489US8748606B24,6-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Jun 10, 2014·8 cites·4 claims
- 1589US8242271B2Heterocyclic compounds and uses thereofSINGH JUSWINDER·Filed 2008·Granted Aug 14, 2012·9 cites·31 claims
- 1689US7880002B2Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonistsMILLENNIUM PHARM INC·Filed 2005·Granted Feb 1, 2011·10 cites·17 claims
- 1788US10179793B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2016·Granted Jan 15, 2019·7 cites·17 claims
- 1888US8445498B24,6-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted May 21, 2013·8 cites·17 claims
- 1987US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 2087US10533007B2NLRP3 modulatorsInnate Tumor Immunity·Filed 2017·Granted Jan 14, 2020·10 cites·2 claims
- 2186US8168788B2Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonistsCARSON KENNETH G·Filed 2010·Granted May 1, 2012·8 cites·15 claims
- 2286US7977350B2CCR1 antagonists and methods of use thereforMILLENNIUM PHARM INC·Filed 2010·Granted Jul 12, 2011·5 cites·16 claims
- 2386US7951950B2PGD2 receptor antagonists for the treatment of inflammatory diseasesMILLENNIUM PHARM INC·Filed 2006·Granted May 31, 2011·14 cites·39 claims
- 2485US12351580B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2023·Granted Jul 8, 2025·0 cites·6 claims
- 2585US9040541B24,6-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2013·Granted May 26, 2015·5 cites·24 claims
- 2685US8586600B2Heterocyclic compounds and uses thereofSINGH JUSWINDER·Filed 2012·Granted Nov 19, 2013·6 cites·12 claims
- 2785US7732459B2CCR1 antagonists and methods of use thereforMILLENNIUM PHARM INC·Filed 2007·Granted Jun 8, 2010·4 cites·12 claims
- 2885US7541365B2Chemokine receptor antagonists and methods of use thereforMILLENNIUM PHARM INC·Filed 2006·Granted Jun 2, 2009·6 cites·11 claims
- 2984US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 3084US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 3184US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 3284US9393246B24,6-disubstituted pyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2015·Granted Jul 19, 2016·3 cites·11 claims
- 3383US9067929B2Heterocyclic compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Jun 30, 2015·4 cites·22 claims
- 3483US8901156B2Compounds and methodsBALOGLU ERKAN·Filed 2011·Granted Dec 2, 2014·8 cites·22 claims
- 3583US8058287B2Chemokine receptor antagonists and methods of use thereforLULY JAY R·Filed 2009·Granted Nov 15, 2011·4 cites·5 claims
- 3681US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 3781US9163061B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2008·Granted Oct 20, 2015·5 cites·31 claims
- 3880US8648197B2Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonistsCARSON KENNETH G·Filed 2012·Granted Feb 11, 2014·4 cites·16 claims
- 3979US7211672B2PGD2 receptor antagonists for the treatment of inflammatory diseasesMILLENNIUM PHARM INC·Filed 2003·Granted May 1, 2007·12 cites·21 claims
- 4078US11072612B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 27, 2021·1 cites·5 claims
- 4178US9556426B2Protein kinase conjugates and inhibitorsSINGH JUSWINDER·Filed 2010·Granted Jan 31, 2017·3 cites·48 claims
- 4278US8394817B2CCR1 antagonists and methods of use thereforCARSON KENNETH G·Filed 2011·Granted Mar 12, 2013·2 cites·15 claims
- 4377US7271176B2Chemokine receptor antagonists and methods of use thereofKYOWA HAKKO KOGYO KK·Filed 2002·Granted Sep 18, 2007·12 cites·25 claims
- 4477US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4575US7329755B2CCR8 inhibitorsMILLENNIUM PHARM INC·Filed 2003·Granted Feb 12, 2008·11 cites·9 claims
- 4674US11760735B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2022·Granted Sep 19, 2023·0 cites·9 claims
- 4774US10662195B2Protein kinase conjugates and inhibitorsCELGENE AVILOMICS RES INC·Filed 2016·Granted May 26, 2020·1 cites·1 claims
- 4873US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 4973US11827632B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Nov 28, 2023·0 cites·23 claims
- 5073US9296704B2Substituted pyrimidines as protein kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2014·Granted Mar 29, 2016·1 cites·5 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shomir Ghosh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →